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Introduction
Klebsiella pneumoniae is a critical multidrug-resis-
tant (MDR) bacterium in humans responsible for 
numerous hospital infections linked to high morbid-
ity and mortality since treatment options are limited 
(Navon-Venezia et al. 2017). K. pneumoniae from the 
family Enterobacteriaceae, occurs in the human and 
animal gastrointestinal tract microbiome. It is a com-
monly found opportunistic pathogen associated with 
the hospital environment and, overall, accountable for 
approximately a third of all Gram-negative infections. 
It has a role in extraintestinal infections, such as urinary 
tract infections, pneumonia, surgical site infections, cys-
titis, and life-threatening infections, including endo-
carditis and septicemia. It is also a significant cause of 
severe community-onset infections, such as necrotizing 
pneumonia, endogenous endophthalmitis, and pyogenic 
liver abscesses (Podschun and Ullmann 1998).
With the ever-growing antibiotic resistance, K. pneu­
moniae is a pathogen recognized for its antibiotic resist-
ance; hence, it is categorized as an ESKAPE organism, 
besides other essential MDR pathogens (Boucher et al. 
2009). The accumulation of ARGs by K. pneumoniae, 
by de novo mutations, is continuous under antibiotic 
selective pressure, and through the acquisition of plas-
mids and transferable genetic elements, it stimulates 
extensively drug-resistant (XDR) strains harboring 
a ‘super resistome’. In the past twenty years, many high-
risk (HiR) MDR and XDR K. pneumoniae sequence 
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A b s t r a c t
Carbapenem-resistant Klebsiella pneumoniae (CRKP) is an important bacterium of nosocomial infections. In this study, CRKP strains, 
which were mainly isolated from fecal samples of 14 patients in three wards of the hospital in the Silesia Voivodship, rapidly increased from 
February to August 2018. Therefore, we conducted microbiological and molecular studies of the CRKP isolates analyzed. Colonized patients 
had critical underlying diseases and comorbidities; one developed bloodstream infection, and five died (33.3%). Antibiotic susceptibilities 
were determined by the E-test method. A disc synergy test confirmed carbapenemase production. CTX-Mplex PCR evaluated the presence 
of resistance genes blaCTX-M-type, blaCTX-M-1, blaCTX-M-9, and the genes blaSHV, blaTEM, blaKPC-2, blaNDM-1, blaOXA-48, blaIMP, and blaVIM-1 was detected 
with the PCR method. Clonality was evaluated by Multi Locus Sequence Typing (MLST) and Pulsed Field Gel Electrophoresis (PFGE). Six 
(40%) strains were of XDR (Extensively Drug-Resistant) phenotype, and nine (60%) of the isolates exhibited MDR (Multidrug-Resistant) 
phenotype. The range of carbapenem minimal inhibitory concentrations (MICs, µg/mL) was as follows doripenem (16 to > 32), ertapenem 
(> 32), imipenem (4 to > 32), and meropenem (> 32). PCR and sequencing confirmed the blaCTX-M-15, blaKPC-2, blaOXA-48, and blaVIM-1 genes in 
all strains. The isolates formed one large PFGE cluster (clone A). MLST assigned them to the emerging high-risk clone of ST147 (CC147) 
pandemic lineage harboring the blaOXA-48 gene. This study showed that the K. pneumoniae isolates detected in the multi-profile medical 
centre in Katowice represented a single strain of the microorganism spreading in the hospital environment. 
K e y w o r d s: clonal dissemination, carbapenem-resistant Klebsiella pneumoniae, hospital, PFGE, MLST
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types have appeared that exhibit great capacity of caus-
ing multicontinental outbreaks and continued global 
dissemination (Navon-Venezia et al. 2017).
Currently, the spread of carbapenem-resistant 
K. pneumoniae (CRKP) has become a severe problem 
in the molecular epidemiology of hospital infections. 
Frequently, carbapenems serve as the last resort in 
the effective treatment of serious infections caused by 
multidrug-resistant bacteria. Enzymes that hydrolyze 
carbapenems, called carbapenemases, are the major 
cause of carbapenem resistance (Matsumura et al. 
2017). The molecular classes A, B, and D carbapene-
mases are rapidly disseminated worldwide, challenging 
the treatment of Gram-negative infections (Nordmann 
and Poirel 2014). Recent reports have demonstrated 
that various carbapenem-hydrolyzing enzymes are 
disseminated worldwide in CRKP isolates. The fast 
evolution of carbapenem resistance quickly evolved 
in Enterobacteriaceae in the past decade and became 
a developing global threat. The majority of studies on 
antibiotic-resistant K. pneumoniae focus on character-
izing carbapenemase producers (KPC, NDM, VIM, 
and OXA-48), various clonal groups or complexes 
(e.g., CG15, CG17, CG258, or CC147), and epidemic 
plasmids (IncA/C, IncFII, IncL/M, and IncN) that have 
been suggested to participate in their global expansion 
(Nordmann and Poirel 2014). Carbapenemase co-pro-
ducers have been reported in distinct geographic loca-
tions: European countries (France, Germany, Greece, 
Italy, and Poland), Israel, the United States, China, and 
West Asia (Turkey) (Baraniak et al. 2011; Nordmann 
and Poirel 2014; Baraniak et al. 2015; Guo et al. 2016; 
Lee et al. 2016; Zautner et al. 2017; Bukavaz et al. 2018). 
The majority of KPC-producing microorganisms 
also express β-lactamases and possess genes conferring 
resistance to other antimicrobials, i.e. aminoglycosides, 
fluoroquinolones, or co-trimoxazole (Nordmann and 
Poirel 2014). The resistance rates vary significantly 
across countries; MDR K. pneumoniae is endemic in 
Mediterranean countries, and Eastern and South-
Western Europe. It stems from ESβL production in 
more than 50–60% strains, and non-susceptibility to 
third-generation cephalosporins, fluoroquinolones, and 
aminoglycosides (Navon-Venezia et al. 2017).
In 2011, the National Reference Center for Sus-
ceptibility Testing (NRCTS) and the KPC-PL Study 
Group published the first report from Poland that 
presented the molecular characteristics of K. pneumo­
niae producing KPC carbapenemases (Baraniak et al. 
2011). Between 2011 and 2015, the bacteria caused 
1,067  infection outbreaks; among them, 123 were 
caused by K. pneumoniae, and a higher number of 
outbreaks were reported from Masovian and Silesian 
voivodships (Baraniak et al. 2011). Poland belongs 
to the countries of the highest rate of K. pneumoniae 
isolates’ resistance to all groups of drugs subjected to 
monitoring, and these rates are twice as high as else-
where in the European Union (EU)/European Eco-
nomic Area (EEA). In these countries, resistant 
K. pneu moniae isolates consist on average 20.5% of all 
MDR multidrug-resistant strains (Bukavaz et al. 2018). 
Given the abovementioned data and the increased 
frequency of isolation of CRKP strains from the hospi-
tal environment, we conducted a microbiological and 
molecular characterization of carbapenem-resistant 
K. pneumoniae isolates with emphasis on the antibiotic 
resistance profile, identification of ESβL genes, detec-




Hospital settings and sample collection. The study 
was performed in the Upper-Silesian Medical Centre 
of the Silesian Medical University in Katowice (GCM), 
one of the largest multi-profile medical centres, and 
one of the largest hospitals in Poland. The hospital 
consists of 24 departments and treats over 160 thou-
sand patients per year. Between February and August 
2018, 15 non-duplicate CPKP isolates were collected 
from fecal samples of 14  patients admitted to three 
hospital wards characterized below. The Department 
of Neurology with the Stroke Sub-department (NR) 
receives 1,750 admissions per year and has 14 rooms 
with 44  beds; the Department of Internal Medicine 
and Rheumatology (REU) receives 1,935 admissions 
per year and has 12  rooms with 37  beds, and the 
Department of Anaesthesia and Intensive Care (OAIT) 
receives 1,750 admissions per year and has five rooms 
with ten beds (Table I). A total of 505 Enterobacteriaceae 
isolates were obtained from the patients in these wards 
over one-year.
Bacterial identification, antimicrobial suscep-
tibility testing and phenotypic screening. Bacterial 
identification and preliminary susceptibility testing 
were performed using the automated VITEK® 2 Com-
pact System (bioMérieux, France). The MICs of the 
23  antimicrobial agents were evaluated with E-test 
strips (AB BIODISK, bioMérieux, France). MIC value 
results were interpreted according to the EUCAST 
breakpoints (EUCAST 2019). All isolates were screened 
phenotypically for the presence of KPC-, OXA-48-, and 
metallo-β-lactamases (MBL). Double-disc synergy tests 
(DDST) were carried out to confirm ESβL production 
(CLSI 2018) and to detect MBL production, as pub-
lished previously (Matsumura et al. 2017). The pheno-
typic detection of KPC-producing isolates was assessed 
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by an available protocol (Doi et al. 2008). According 
to the protocol, the boronic acid combined-disk tests 
using meropenem (10 µg) as the antibiotic substrate 
and 3-aminophenylboronic acid (3-APBA) (300 g, 
Sigma-Aldrich) as the inhibitor of KPC production 
was used. The detection of OXA-48 was performed in 
line with the EUCAST guidelines (Shaker et al. 2018). 
MDR and XDR were defined according to a standard-
ized international document (Magiorakos et al. 2012).
Extended-spectrum β-lactamase genes (ESβLs) 
identification. Polymerase chain reaction (PCR), 
as described by Caltagirone et al. (2017) was used 
to determine blaSHV and blaTEM. CTX-Mplex PCR 
was used to detect blaCTX-M-type, blaCTX-M-1, and blaCTX-M-9 
(Xu et al. 2005).
Carbapenemase genes detection. The existence 
of carbapenemase encoding genes (blaKPC-2, blaNDM-1, 
blaOXA-48, blaIMP, and blaVIM-1) was confirmed using the 
PCR method (Bukavaz et al. 2018).
PFGE. The genetic relatedness of isolates was investi-
gated using the Pulsed Field Gel Electrophoresis (PFGE) 
method, following genomic DNA extraction and diges-
tion with XbaI endonuclease (Fermentas, Lithuania), as 
described previously (Han et al. 2013). Salmonella ente­
rica subsp. enterica serovar Braenderup strain H9812 
(ATCC® BAA664™) and K. pneumoniae ATCC® BAA-
1705™ were used as reference markers. PFGE band-
ing patterns were compared using Bio Numerics v.6.5 
(Applied Maths, Belgium) software. The relatedness was 
determined by the unweighted pair group method using 
the average linkages (UPGMA), and the similarity of 
bands was calculated using the Dice coefficient.
MLST. Multilocus Sequence Typing (MLST) was con- 
ducted with the use of seven conserved housekeeping 
genes (gapA, infB, mdh, pgi, phoE, rpoB, and tonB) (Guo 
et al. 2016). A complete protocol of the MLST proce-
dure, including the allelic profile and sequence type (ST) 
assignment techniques, is available in MLST databases.
Results
Patients’ characteristics. Patients’ characteristics 
is presented in Table I. During seven months, the 
15 K. pneumoniae isolates were collected from fourteen 
patients aged 65.5 years on average. The average dura-
tion of hospitalization was 37 days. All patients were 
found to be colonized by similar CRKP isolates. One 
patient developed a bloodstream infection (only blood 
isolate available) and was successfully treated with 
linezolid and colistin. Two of the improved patients 
were treated with carbapenem. Five patients died; their 
deaths were not associated with any particular etiology, 
though. CRKP strains were isolated at various stages 
of patients’ hospital stay. An average time from patient 
admission to the microorganism isolation was 16 days; 
in patient no. 3 the corresponding period was 64 days, 
while in patients nos. 1 and 5 – the period was only five 
days. None of the patients had traveled abroad shortly 
before their hospital admissions, so any travel experi-
ence could explain the colonization. 
Epidemiologic investigation. The studied K. pneu­
moniae isolates’ epidemic curve exhibited a bimodal dis-
tribution of cases with two peaks separated by 148 days 
(Fig. 1). It could indicate double discrete periods (Febru-
ary-March 2018 and July-August 2018) with unobserved 
cases in January, April, May, and June. The NR ward was 
involved in these distinct periods. Following the index 
case, four new cases were registered in the OAIT, six 
cases in the NR, and three in the REU (Table I). 
Fig. 1. Gantt diagram depicting a timeline of patients’ admissions in relationship with the three wards and the length
of stay in each ward. Epidemic curve based on the number of K. pneumoniae isolated in the time frame of the study.
Abbreviations: OAIT-Department of Anaesthesia and Intensive Care, NR-Department of Neurology
with the Stroke Subdepartment, REU-Department of Internal Medicine and Rheumatology.
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Antimicrobial resistance. The antimicrobial resist-
ance profiles for the isolates are listed in Table II. We 
have classified nine (60%) strains as MDR and six (40%) 
as XDR. All isolates showed resistance to penicillins, 
cefalosporins, carbapenems (doripenem, ertapenem, 
meropenem), quinolone (ciprofloxacin), aminoglyco-
sides (amikacin, gentamycin, netilmycin, tobramycin), 
and other antibiotics (aztreonam, trimethoprim/sul-
famethoxazole, fosfomycin). Eleven isolates (73.3%) 
were sensitive to amikacin, two isolates (13.3%) were 
in the intermediate range with the MIC values equal 
to 12 µg/ml, and two isolates (13.3%) were resistant. 
Moreover, seven strains (42.8%) were resistant to tige-
cycline, five (35.7%) were in the intermediate range 
with the MIC values above 2 µg/ml. Interestingly, two 
isolates (13.3%) showed susceptibility to imipenem, 
and the resistance of one isolate (6.7%) to imipenem 
was within the intermediate range.
Phenotypic screening of carbapenemases and 
associated β-lactamases. In all K. pneumoniae isolates 
(n = 15, 100%), the ESβL mechanism was not found in 
phenotypic tests. Also, MBL production was not pheno-
typically detected in these isolates. However, all strains 
were positive for K. pneumoniae carbapenemase (KPC) 
production by the modified Hodge test (n = 15, 100%). 
In addition, phenotyping detection of carbapenem-
resistant class D using the carbapenemase detection set 
with temocillin disc (30 µg) revealed that all isolates 
were positive for OXA-48 (n = 15, 100%). 
β-lactamase genes detection. PCR amplification 
and sequencing analysis confirmed the presence of 
blaKPC-2, blaOXA-48, blaVIM-1 in all 15 of the K. pneumoniae 
isolates. In addition, the only identified blaCTX-M variant 
in all 15 strains was blaCTX-M-15. The results are presented 
in Fig. 2. No isolate was found to be positive for blaSHV, 
blaTEM, blaNDM-1, and blaIMP.
Molecular epidemiology. Out of fifteen isolates 
concerned, all belonged to a single PFGE cluster 
(clone A) (Fig. 2).
Moreover, an MLST analysis allowed us to classify 
all isolates as the sequence type ST147 (allelic profile: 
3-4-6-1-7-4-38) belonging to the CC147 clonal complex. 
It confirmed clonal relationships between the isolates.
Discussion
The presented work stems from the problem of 
clonal dissemination of KPC-2, VIM-1, and OXA-
48-producing K. pneumoniae ST147 noticed in one 
hospital in Katowice, the Silesian Voivodeship, Poland.
K. pneumoniae belongs to Gram-negative bacteria 
of the family Enterobacteriaceae. The pathogens can 
easily cause hazardous epidemic outbreaks and spread 
globally in the form of clones with increased virulence 
and epidemicity. These features are associated with the 
widespread presence of Enterobacteriaceae in humans 
(gastrointestinal carriage) and their great importance 
as frequent infection etiologic agent in facilities that 
carry out inpatient and outpatient treatment (Navon- 
Venezia et al. 2017). Studies that focus on K. pneumoniae 
are therefore desired, as they provide vital scientific 
Fig. 2. Dendrogram of XbaI-digested genomic DNA from carbapenemase-co-producing K. pneumoniae isolates, additionally presenting 
the results of PCRs for genes encoding carbapenemases and other β-lactamase. PFGE settings: similarity coefficient, Dice;
optimization, 1%; tolerance, 1%; clustering method, UPGMA. 
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grounds for the relevant action to be taken in the field 
of public health in respect of molecular epidemiology. 
This study’s subject was a particular group of micro-
organisms classified as bacterial alarm agents (BCA) of 
particular virulence or resistance, i.e., carbapenemase-
producing K. pneumoniae strains belonging to the 
order Enterobacterales. All K. pneumoniae isolates were 
derived from intestinal colonization cases in the patients 
studied. This work elaborated epidemiological opinions 
on the BCA epidemic threat occurrence in the multi-
profile medical center in Katowice. It was also based 
on suspicion of an epidemic outbreak since we noticed 
clonal dissemination of several CRKP isolates and one 
case of symptomatic hospital infection with a blood 
CRKP strain. This strain was isolated in a given depart-
ment 48 hours after the patient’s admission. The coloni-
zation of fourteen consecutive hospitalized patients with 
the same strain of the CRKP was also reported. CRKP 
isolates had unique properties such as the accumulation 
of numerous antibiotic resistance mechanisms and the 
capability to persist in a hospital environment. It resulted 
in special attention being paid to CRKP strains’ health 
care risk (Navon-Venezia et al. 2017). The genes encod-
ing KPC, MBL, and OXA-48 are located on the so-called 
mobile genetic elements (plasmids, transposons) that 
allow effective spreading within bacterial populations. 
The genes encoding KPC carbapenemases (blaKPC) are 
located on the Tn4401 transposon located on plasmids 
with different types of replicons (IncF, IncL/M, ColE1, 
IncR, and IncX3). These plasmids show the ability to 
conjugate and propagate the blaKPC genes to new bacte-
rial populations (Baraniak et al. 2011). 
On the other hand, the most important families of 
the MBL acquired are the enzymes IMP and VIM occur-
ring both in non-fermenting and intestinal bacilli. The 
blaIMP and blaVIM genes always exist as cassettes inserted 
into integrons. In turn, integrons can be located on 
transposons and move with them between DNA mole- 
cules (Izdebski et al. 2018b). ESβL enzymes exist mainly 
as acquired, plasmid-encoded β-lactamases. ESβL-enco- 
ding genes are often located on conjugation plasmids 
(IncFII, IncI), including those with a broad host range 
(IncA/C, IncL/M). It allows them to spread rapidly, also 
between strains belonging to different species. Frequ-
ently noted are encoded by blaCTX-M genes ESβL enzymes, 
active against cefotaxime CTX-M and localized on plas-
mids in Enterobacterales (Izdebski et al. 2018a; 2018b). 
The isolates’ antibiotic susceptibility testing con-
firmed the β-lactamase antibiotics resistance profile 
typical for carbapenemase producers, as presented else-
where (Zacharczuk et al. 2011; Guo et al. 2016; Izdeb-
ski et al. 2018a). All strains expressed high-level resist-
ance to doripenem, ertapenem, meropenem, although 
they showed varying levels of resistance to imipenem. 
Ertapenem is the carbapenem that has been suggested as 
most suitable for detecting the presence of blaKPC, which 
was confirmed by high MIC values for ertapenem 
(> 32 μg/ml) in the present study. The presence of KPC 
does not always result in expression of in vitro resistance 
to imipenem or meropenem, as this carbapenemase 
shows limited efficiency of β-lactam ring hydrolysis 
in carbapenem particles. In this study, E-test showed 
resistance to ertapenem of 7/25804, 11/25808, 13/25810 
strains, and susceptibility or medium susceptibility to 
imipenem (MICs 4–8 μg/ml), while PCR confirmed 
the presence of the blaKPC-2 gene in all three isolates. 
Imipenem and meropenem resistance of other strains 
might have resulted from decreased outer membrane 
permeability or other β-lactamases providing a syner-
gistic effect with KPC (Protonotariou et al. 2018). The 
strains’ resistance to third-generation cephalospor-
ins confirmed this hypothesis similarly to the vari-
ous β-lactamases production by K. pneumoniae. The 
variability in CRKP strains’ carbapenem susceptibility 
illustrates the difficulties encountered while trying to 
identify strains producing carbapenemases only with the 
E-testing of resistance profiles. To reliably identify such 
strains, additional and more specific techniques should 
be applied (Xu et al. 2005; Magiorakos et al. 2012; Han 
et al. 2013; Caltagirone et al. 2017; Bukavaz et al. 2018).
The blaKPC-2, blaOXA-48, and blaVIM-1 carbapenemase 
encoding genes and an additional blaCTX-M-15 cefotaxi-
mase encoding genes have been found to coexist in 
all the strains concerned. Lee et al. (2016) found that 
K. pneumoniae can carry multiple β-lactamase genes 
in the same strain, which could be partly responsible 
for the pathogen’s selective success. All types of the bla 
genes were reported in combinations for this species 
(Lee et al. 2016). So far, K. pneumoniae that produce 
KPC-2 and KPC-3 carbapenemases have been fre-
quently found in Europe, including Poland (Baraniak 
et al. 2011; Zacharczuk et al. 2011; Baraniak et al. 2015; 
Grundmann et al. 2017). On the other hand, Mat-
sumura et al. (2017) presented the global dissemination 
of Enterobacteriaceae strains carrying the blaVIM genes. 
The VIM-producing Enterobacteriaceae are generally 
present in Europe, particularly in Greece, Spain, Hun-
gary, and Italy (Matsumura et al. 2017). Significantly, 
an increasing problem with VIM-producing K. pneu­
moniae has been recorded in Greece, where the strains 
have accounted for the deaths of 48% of patients over 
the last two years (Protonotariou et al. 2018). In Poland, 
Izdebski et al. (2018b), collected one hundred and nine-
teen cases of VIM/IMP-positive Enterobacteriaceae in 
the period from 2006 to 2012, and showed many spe-
cific or entirely new features of these microorganisms, 
undoubtedly related to the properties of pathogens iso-
lated in the abovementioned central-southern countries 
Europe, including several likely imported from abroad 
(e.g., from Greece) (Izdebski et al. 2018b).
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The strains containing OXA-48 β-lactamases pro-
vide another example of rapid immigration of harmful 
microorganisms to Europe from their endemic regions, 
mostly eastern and southern Mediterranean countries 
(Egypt, Morocco, and Turkey). OXA-48-like-positive 
strains cause hospital outbreaks of epidemics in Bel-
gium, France, Netherlands, Germany, Spain, and other 
countries (Nordmann and Poirel 2014; Grundmann 
et al. 2017). In the most recent report developed by 
OXA-48-PL Study Group monitoring the Enterobac­
teriaceae OXA-48-positive strains’ spread, the authors 
demonstrate that these strains have been isolated rela-
tively rarely in Poland (Izdebski et al. 2018a). It was con-
firmed by other European and international research 
teams (Nordmann and Poirel 2014; Grundmann et al. 
2017). Conjugative transfer of a specific plasmid group 
is regarded to be the central mechanism in the spread 
of OXA-48 among the Enterobacteriaceae populations 
(Nordmann and Poirel 2014).
The high MIC values (> 256 µg/ml) for cefotax-
ime may suggest that the strains produced CTX-M 
β-lactamases. Multiplex PCR and sequencing have 
confirmed blaCTX-M-15 presence in all isolates. The pres-
ence of various CTX-M β-lactamases in K. pneumoniae 
in Poland has been confirmed by other research teams 
(Baraniak et al. 2011; Izdebski et al. 2018a; 2018b). No 
blaSHV or blaTEM have been identified among the isolates. 
These results are in line with the persisting trend of 
diminished prevalence of hospital-associated K. pneu­
moniae strains producing SHV or TEM β-lactamases, 
which has also been noted by other scientists (Rodri-
gues et al. 2014). The type of ESβLs present in K. pneu­
moniae shifted in the 2000s, which caused outbreaks 
in hospitals due to the acquisition of plasmids and 
transposons encoding blaCTX-M-type ESβLs, consequently 
resulting in the predominance of CTX-M-producing 
strains (Calbo and Garau 2015).
Among non-β-lactam antibiotics, colistin has shown 
the highest activity towards the strains concerned. 
Similar results have been published by other authors 
(Zacharczuk et al. 2011). Among aminoglycosides, 
amikacin showed the highest activity. The vast major-
ity of strains (92.8%) were susceptible to amikacin, 
unlike in China, where total K. pneumoniae resistance 
to amikacin was demonstrated (Guo et al. 2016). The 
other aminoglycosides (gentamicin, netilmicin, and 
tobramycin) were nonreactive to the CRKP isolates 
concerned, in line with data reported by other authors 
(Zacharczuk et al. 2011; Guo et al. 2016). On the other 
hand, Bukavaz et al. (2018) presented other aminogly-
coside susceptibility profiles in CRKP strains. These 
discrepancies are most likely due to different quanti-
ties or origins of the strains concerned, though they 
might as well be related to particular hospitals’ or ward’s 
antibiotic policies. 
The present analysis has shown a relatively high 
percentage of isolates resistant to tigecycline (42.8%), 
a synthetic minocycline analogue with a broad spec-
trum of activity. The antibiotic is successfully applied 
to treat infections caused by multi-resistant bacterial 
strains, including K. pneumoniae. During tigecycline 
treatment, Enterobacteriaceae representatives, includ- 
ing CRKP strains, may become resistant to the anti-
biotic, as evidenced by Pfarrell et al. (2018). They dem-
onstrated cross-resistance between tigecycline and 
minocycline in resistant Enterobacteriaceae strains due 
to the MDR pumps, which remove drugs from cells. 
The distribution of acquired tigecycline resistance can 
vary depending on the geographic location or time; 
therefore, it is recommended to concern data on local 
resistance, particularly while treating severe infections 
(Pfarrell et al. 2018).
Genetic similarity of CRKP isolates was deter-
mined by comparing PFGE profiles (Han et al. 2013). 
This method has been widely used by European and 
non-European research teams that study epidemic out-
breaks of K. pneumoniae and evidence global spread of 
this species’ epidemic clones (Guo et al. 2016; Bukavaz 
et al. 2018; Protonotariou et al. 2018). All K. pneu­
moniae strains analyzed in this study belonged to 
ST147 (CC147). Navon-Venezia et al. (2017) reported 
that ST147 K. pneumoniae clone spread globally. The 
involvement of this pandemic clone in the spread of 
CTX-M-15 and other carbapenemases in European, 
Asian, and Middle East countries was confirmed by 
others (Rodrigues et al. 2014; Guo et al. 2016; Zautner 
et al. 2017). The data found in the literature on K. pneu­
moniae clonal organization has been confirmed by 
research focused on the molecular epidemiology of 
infections due to antibiotic-resistant Enterobacteriaceae 
(Guo et al. 2016; Protonotariou et al. 2018).
Because of the clonal nature of the isolates studied, 
the clinical data about their origin was reviewed to 
examine whether the same clonal type was circulating 
in the three various hospital wards. The study focused 
mainly on stroke patients or patients suffering from 
cardiovascular complications who were transferred to 
multiple-bed hospital rooms in Stroke Recovery Units, 
which were the only places where they were in touch. 
Moreover, it is plausible that the neurology ward played 
a major role in disseminating the bacteria throughout 
the hospital. The spread of the pathogen isolates across 
three different hospital wards could imply that the per-
sonnel who can access all hospital wards freely, unlike 
the patients and their relatives, might have transmitted 
the infections. Scientific literature emphasizes the role 
of hospitalization (and its duration) in the process of 
bacterial colonization. The frequency of gastrointesti-
nal colonization with K. pneumoniae strains in hospi-
talized patients was high in our study. Gastrointestinal 
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colonization with CRKP is an important risk factor 
for infections with strains of the same phenotype due 
to the easy transfer of the genes and strains’ persistence 
in hospital environments, which hinders their eradica-
tion. This research evidences K. pneumoniae adaptation 
typical of endemic hospital strains, which are corrobo-
rated by the accumulation of locally spreading resist-
ance mechanisms to the antibiotics most commonly 
used for therapeutic purposes.
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